Ophthalmic Surg Lasers Imaging Retina. 2020 Oct 1;51(10):542-544. doi: 10.3928/23258160-20201005-01.
The authors present their concerns surrounding data presented in studies from 2018 and 2020 regarding very low dose bevacizumab for the treatment of retinopathy of prematurity. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:542-544.].
作者对 2018 年和 2020 年关于极低剂量贝伐单抗治疗早产儿视网膜病变的研究数据提出了担忧。[眼科学与激光成像视网膜手术。2020;51:542-544]。